ECSP088360A - Métodos para preparar derivados de ácido glutámico - Google Patents

Métodos para preparar derivados de ácido glutámico

Info

Publication number
ECSP088360A
ECSP088360A EC2008008360A ECSP088360A ECSP088360A EC SP088360 A ECSP088360 A EC SP088360A EC 2008008360 A EC2008008360 A EC 2008008360A EC SP088360 A ECSP088360 A EC SP088360A EC SP088360 A ECSP088360 A EC SP088360A
Authority
EC
Ecuador
Prior art keywords
glutamic acid
methods
prepare derivatives
derivatives
prepare
Prior art date
Application number
EC2008008360A
Other languages
English (en)
Inventor
David Michael Blum
Ronald Stanley Michalak
Joseph Zeldis
Mel Jennings
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP088360A publication Critical patent/ECSP088360A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se relaciona con métodos novedosos para la preparación de derivados de ácido glutámico e intermedios de estos, y tales compuestos preparados por los métodos novedosos.
EC2008008360A 2005-10-13 2008-04-10 Métodos para preparar derivados de ácido glutámico ECSP088360A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72644105P 2005-10-13 2005-10-13

Publications (1)

Publication Number Publication Date
ECSP088360A true ECSP088360A (es) 2008-05-30

Family

ID=37119907

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008360A ECSP088360A (es) 2005-10-13 2008-04-10 Métodos para preparar derivados de ácido glutámico

Country Status (18)

Country Link
US (1) US7541485B2 (es)
EP (1) EP1934171A1 (es)
JP (1) JP2009511578A (es)
KR (1) KR20080058436A (es)
CN (1) CN101282927A (es)
AR (1) AR057451A1 (es)
AU (1) AU2006299918A1 (es)
BR (1) BRPI0617348A2 (es)
CA (1) CA2624866A1 (es)
CR (1) CR9885A (es)
EC (1) ECSP088360A (es)
GT (1) GT200600305A (es)
IL (1) IL190729A0 (es)
NO (1) NO20081617L (es)
PE (1) PE20070526A1 (es)
RU (1) RU2008113222A (es)
TW (1) TW200740729A (es)
WO (1) WO2007044100A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR061420A1 (es) * 2006-06-02 2008-08-27 Wyeth Corp Metodos para preparar derivados de acido glutamico e intermediarios del mismo
US20100216886A1 (en) * 2006-11-09 2010-08-26 Wyeth Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
PL2760287T3 (pl) * 2011-09-30 2020-08-10 Kemira Oyj Zapobieganie degradacji skrobi w procesach wytwarzania masy włóknistej, papieru lub tektury
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
US10526287B2 (en) 2015-04-23 2020-01-07 Constellation Pharmaceuticals, Inc. LSD1 inhibitors and uses thereof
AU2017348100B2 (en) 2016-10-26 2021-08-26 Constellation Pharmaceuticals, Inc. LSD1 inhibitors and medical uses thereof
TW202246232A (zh) 2021-02-19 2022-12-01 英商蘇多生物科學有限公司 Ｔｙｋ２抑制劑及其用途
TW202246233A (zh) 2021-02-19 2022-12-01 英商蘇多生物科學有限公司 Tyk2抑制劑及其用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2440649A (en) * 1948-04-27 Quinazoline
GB1108819A (en) 1964-07-31 1968-04-03 Rotta Research Lab Derivatives of 2-acylaminobicarboxylic acids and method for preparing same
DE3332633A1 (de) 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5424334A (en) 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
CA2150550A1 (en) 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
JPH06192199A (ja) 1992-12-25 1994-07-12 Mitsubishi Kasei Corp ケトン誘導体
US5563127A (en) * 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
ES2199247T3 (es) 1994-03-11 2004-02-16 Pharmacopeia Drug Discovery, Inc. Derivados de sulfonamida y su uso.
GB2292149A (en) 1994-08-09 1996-02-14 Ferring Res Ltd Peptide inhibitors of pro-interleukin-1beta converting enzyme
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
JP3353301B2 (ja) 1995-07-24 2002-12-03 藤沢薬品工業株式会社 Ｐｌａ▲下２▼阻害剤としてのエステル類およびアミド類
WO1997021690A1 (en) 1995-11-28 1997-06-19 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases
AU7937298A (en) 1997-07-08 1999-02-08 Ono Pharmaceutical Co. Ltd. Amino acid derivatives
JP4129069B2 (ja) 1997-09-16 2008-07-30 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
JP4090541B2 (ja) 1997-10-15 2008-05-28 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
AU3366899A (en) 1998-03-27 1999-10-18 Regents Of The University Of California, The Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
US6242422B1 (en) * 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
US7157430B2 (en) * 1998-10-22 2007-01-02 Idun Pharmaceuticals, Inc. (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6265610B1 (en) * 1999-01-12 2001-07-24 The University Of North Carolina At Chapel Hill Contrast media for angiography
EP1189881B2 (en) 1999-05-07 2013-01-23 Encysive Pharmaceuticals, Inc. Propanoic acid derivatives that inhibit the binding of integrins to their receptors
US6723711B2 (en) 1999-05-07 2004-04-20 Texas Biotechnology Corporation Propanoic acid derivatives that inhibit the binding of integrins to their receptors
US6493791B1 (en) * 1999-12-20 2002-12-10 Intel Corporation Prioritized content addressable memory
CN1366518A (zh) 2000-04-25 2002-08-28 三星电子株式会社 作为基质金属蛋白酶抑制剂的联苯基丁酸衍生物
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
CA2321348A1 (en) * 2000-09-27 2002-03-27 Blaise Magloire N'zemba Aromatic derivatives with hiv integrase inhibitory properties
JP2002145849A (ja) 2000-11-10 2002-05-22 Kyorin Pharmaceut Co Ltd アルキニルアミノ酸誘導体及びその製造法
US20050049242A1 (en) * 2000-12-21 2005-03-03 W. Edward Robinson Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
AU2003228744A1 (en) 2002-04-29 2003-11-17 The Ohio State University Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic
AU2004266233A1 (en) 2003-08-13 2005-03-03 Amgen, Inc. Melanin concentrating hormone receptor antagonist
US20070208166A1 (en) 2003-10-24 2007-09-06 Exelixis, Inc. Tao Kinase Modulators And Method Of Use
CA2548513A1 (en) 2003-12-04 2005-07-07 Wyeth Biaryl sulfonamides and methods for using same
ZA200605247B (en) 2003-12-15 2007-10-31 Japan Tobacco Inc N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
JP2007528404A (ja) 2004-03-09 2007-10-11 エラン ファーマシューティカルズ，インコーポレイテッド 置換された尿素およびカルバメート、フェナシル−２−ヒドロキシ−３−ジアミノアルカン、ならびにベンズアミド−２−ヒドロキシ−３−ジアミノアルカン系のアスパラギン酸プロテアーゼ阻害薬
JP5181118B2 (ja) 2005-07-11 2013-04-10 ワイス・エルエルシー グルタミン酸アグリカナーゼ阻害剤
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
AR061420A1 (es) * 2006-06-02 2008-08-27 Wyeth Corp Metodos para preparar derivados de acido glutamico e intermediarios del mismo

Also Published As

Publication number Publication date
AR057451A1 (es) 2007-12-05
US20070088172A1 (en) 2007-04-19
TW200740729A (en) 2007-11-01
BRPI0617348A2 (pt) 2011-07-26
CA2624866A1 (en) 2007-04-19
GT200600305A (es) 2007-02-26
CR9885A (es) 2008-06-16
WO2007044100A1 (en) 2007-04-19
JP2009511578A (ja) 2009-03-19
IL190729A0 (en) 2008-11-03
RU2008113222A (ru) 2009-11-20
AU2006299918A1 (en) 2007-04-19
EP1934171A1 (en) 2008-06-25
KR20080058436A (ko) 2008-06-25
PE20070526A1 (es) 2007-06-11
CN101282927A (zh) 2008-10-08
US7541485B2 (en) 2009-06-02
NO20081617L (no) 2008-05-06

Similar Documents

Publication Publication Date Title
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
ECSP088360A (es) Métodos para preparar derivados de ácido glutámico
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
CY1115893T1 (el) Anti-μολυσματικες πυριμιδινες και χρησεις αυτων
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
HRP20070043A2 (hr) Antivirusna sredstva
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
CU20080174A7 (es) Derivados de amina
NI201100078A (es) Proceso para la preparación de derivados de l-alanina protegidos.
EA200702464A1 (ru) Способы получения фенольных 4-бифенилилазетидин-2-онов
ECSP088151A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
ECSP088383A (es) Tetrahidroquinolinas, su síntesis e intermediarios campo de la invención
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
ECSP088251A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
HN2010001233A (es) Uso derivados de acido tetramico para controlar nematodos
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
EA201001870A1 (ru) Новые кристаллические формы рабепразола натрия
CY1108718T1 (el) Ενισχυται υποδοχεως αμρα
ECSP088933A (es) Métodos para preparar derivados de ácido glutámico y sus intermedios
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
ECSP099599A (es) Procedimientos para la preparación de compuestos de urea sustituidos con piperidinilo